Article info
PDFInflammation and inflammatory bowel disease
Thalidomide reduces tumour necrosis factor α and interleukin 12 production in patients with chronic active Crohn's disease
- Correspondence to:
Dr J Bauditz, Universitätsklinikum Charité, IV Medizinische Klinik und Poliklinik, Schumannstr 20/21, 10117 Berlin, Germany;
juergen.bauditz{at}charite.de
Citation
Thalidomide reduces tumour necrosis factor α and interleukin 12 production in patients with chronic active Crohn's disease
Publication history
- Accepted May 15, 2001
- First published February 1, 2002.
Online issue publication
February 01, 2002
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Gut